Kingdon Capital Management, L.L.C. Heron Therapeutics, Inc. Transaction History

Kingdon Capital Management, L.L.C.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $8.81 Million - $13.5 Million	-505,729 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $5.32 Million - $6.95 Million	-325,092 Reduced 39.13%	505,729 $9.36 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $4.36 Million - $6.75 Million	-257,345 Reduced 23.65%	830,821 $15.4 Million
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $634,217 - $776,402	27,396 Added 2.58%	1,088,166 $26.6 Million
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $5.8 Million - $8.42 Million	263,148 Added 32.99%	1,060,770 $27.5 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $336,930 - $458,786	-11,231 Reduced 1.39%	797,622 $25.2 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $22.6 Million - $36 Million	-857,376 Reduced 51.46%	808,853 $31.4 Million
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $1.17 Million - $1.83 Million	-63,428 Reduced 3.67%	1,666,229 $46 Million
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $4.15 Million - $5.29 Million	-280,668 Reduced 13.96%	1,729,657 $31.3 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $29.5 Million - $33.9 Million	2,010,325	2,010,325 $32.5 Million

178

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $186M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.